Navigation Links
International Probiotics Association Excited To Learn The FDA Has Decided To Issue A New, Revised NDI Draft Guidance
Date:6/21/2012

Zurich, Switzerland (PRWEB) June 21, 2012

The International Probiotics Association (IPA) is delighted that the U.S. Food and Drug Administration (FDA) is taking a second look at the New Dietary Ingredients (NDI) draft guidance, a part of the Dietary Supplement Health and Education Act of 1994 (DSHEA).

“This is a huge move forward for the supplement industry, yet there’s still a lot of work to be done,” said Ioannis Misopoulos, director general of the IPA.

The NDI guidance was intended to assist the dietary supplement industry in deciding when a premarket safety notification for a dietary supplement containing a new dietary ingredient (NDI) was necessary. But, the guidance went so far as to impose significant burdens on manufacturers and especially on manufacturers of probiotic supplements. The initially proposed guidance document went far beyond its intent as it imposed burdens all the way through the probiotic supply chain running from the original manufacturer to the company marketing the finished product.

“We look forward to continuing our work with the FDA to further develop the proper guidance necessary to deliver safe and effective supplements to consumers. And in the meantime, we applaud the successful efforts of industry leaders, in particular Jarrow Formulas for their diligent work and guidance,” continued Misopoulos.

About IPA
The International Probiotics Association (IPA) is an international organization with members equally divided between industry and academia and its goal is to provide a unique forum for the exchange of research and the latest breakthroughs in probiotic technology and new product development. IPA holds NGO status before Codex Alimentarius and is the global voice of probiotics as the majority of the world’s industrial producers are members. Additionally, IPA will work with government bodies and industry to assist in establishing scientific standards for probiotic supplements, probiotic pharmaceutical products and functional foods. IPA will educate consumers on the proven health benefits of probiotics for humans and animals by attending trade shows, health tours/walks and other media functions. IPA promises to always put forth timely, unbiased information to every interested party, and share the documented benefits of probiotics to its international forum of members.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9626721.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Promoting the States Quality of Life, New Jersey Symphony Orchestra to Perform at BIO International Convention
2. International Survey of T2* Cardiovascular Magnetic Resonance in Thalassemia
3. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
4. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
5. Goddard collaborates with international partners on MMS instrument
6. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
7. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May
8. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
9. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
10. Bacterin International Holdings, Inc. Schedules Fourth Quarter 2011 Financial Earnings Conference Call
11. Alchem International Opens Sales and Marketing Office in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):